LTP.AX · LTR PHARMA LIMITED
Australia · RS rating 65 · As of 2026-10-14
| Price | 0.47 AUD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 80 / 40 / 53 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 33 / 24 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +35.4% |
| Market cap (USD) | $61.5M |